Table 4. Stratified analysis based on mode of inheritance for NAT2 SNP (rs1799930) across AML patients and healthy controls.

Model	Genotype	Case n (%)	Control n (%)	OR (95% CI)	P-value	AIC	BIC
Codominant	G/G	20 (69)	95 (43.6)	1	0.018	176.7	187.2
	G/A	6 (20.7)	102 (46.8)	3.58 (1.38–9.29)
	A/A	3 (10.3)	21 (9.6)	1.47 (0.40–5.42)
Dominant	G/G	20 (69)	95 (43.6)	1	0.0096	176	183
	G/A-A/A	9 (31)	123 (56.4)	2.88 (1.25–6.61)
Recessive	G/G-G/A	26 (89.7)	197 (90.4)	1	0.9	182.7	189.7
	A/A	3 (10.3)	21 (9.6)	0.92 (0.26–3.31)
Overdominant	G/G-A/A	23 (79.3)	116 (53.2)	1	0.0057	175.1	182.1
	G/A	6 (20.7)	102 (46.8)	3.37 (1.32–8.60)

OR: Odds ratio

AIC: Akaike information criterion

BIC: Bayesian information criterion